US Map / Washington D.C.
State DC

Clinical Trials in Washington D.C.

Washington D.C. is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Washington D.C. and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 114 actively recruiting studies with Washington D.C. sites out of 114 registered in total. The busiest research areas in Washington D.C. are Solid Tumor, Colorectal Cancer, Neuroblastoma. Leading sponsors running trials in the state include Children's National Research Institute, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Washington D.C. trials break down as Phase 1 (23), Phase 2 (30), Phase 3 (25), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
114
Recruiting Now
114
← Back to US Map
Top Conditions in Washington D.C.
Solid Tumor (4)Colorectal Cancer (3)Neuroblastoma (3)Stroke (3)Crohn Disease (3)Diabetic Peripheral Neuropathic Pain (2)Prostate Cancer (2)Sarcoma (2)Sickle Cell Disease (2)Asthma (2)Large B-cell Lymphoma (2)Becker Muscular Dystrophy (2)

Frequently Asked Questions — Clinical Trials in Washington D.C.

How many clinical trials are currently recruiting in Washington D.C.?
ClinicalMetric currently tracks 114 actively recruiting clinical trials with at least one location in Washington D.C.. The total number of registered studies—including active but not currently enrolling trials—is 114. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Washington D.C.?
Washington D.C. hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Colorectal Cancer, Neuroblastoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington D.C. serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Washington D.C.?
To join a clinical trial in Washington D.C., browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington D.C. maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Washington D.C.

NCT04604418 N/A
Recruiting
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Dise...
Condition
Congenital Heart Disease in Children
Enrollment
10,000 pts
Location
United States, Canada
Sponsor
Boston Children's Hospital
View Trial →
NCT07360080 N/A
Recruiting
Long-Term Outcomes of Teplizumab in Routine Clinical Care
Condition
Type 1 Diabetes
Enrollment
1,000 pts
Location
United States, Germany, Israel
Sponsor
Sanofi
View Trial →
NCT05338697 N/A
Recruiting
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future...
Condition
Stroke
Enrollment
657 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT01109394 N/A
Recruiting
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishme...
Condition
Sarcoma
Enrollment
6,035 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03486873 Phase 3
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tum...
Condition
Solid Tumors
Enrollment
3,500 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06860594 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Th...
Condition
Astrocytoma, IDH-Mutant, Grade 2
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04165070 Phase 1, Phase 2
Recruiting
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) ...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
450 pts
Location
United States, Canada, Hungary
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07224373 Phase 1
Recruiting
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
24 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05137665 N/A
Recruiting
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Ho...
Condition
Amyotrophic Lateral Sclerosis
Enrollment
1,000 pts
Location
United States, Colombia, Puerto Rico
Sponsor
Target ALS Foundation, Inc.
View Trial →
NCT06501781 N/A
Recruiting
Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes...
Condition
HIV Infections
Enrollment
186 pts
Location
United States
Sponsor
University of Maryland, Baltim
View Trial →
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT06585410 Phase 3
Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous S...
Condition
Cutaneous Squamous Cell Carcinoma (CSCC)
Enrollment
369 pts
Location
United States, Australia
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT03206099 N/A
Recruiting
NIAID Centralized Sequencing Protocol
Condition
Atopy
Enrollment
20,000 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT05550298 N/A
Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infectio...
Condition
Hematopoietic Cell Transplant
Enrollment
2,000 pts
Location
United States
Sponsor
Arkansas Children's Hospital R
View Trial →
NCT05786924 Phase 1, Phase 2
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Condition
Non-small Cell Lung Cancer
Enrollment
554 pts
Location
United States, Australia, China
Sponsor
Institut de Recherches Interna
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07110246 Phase 2
Recruiting
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Condition
BRAF V600 Mutation
Enrollment
96 pts
Location
United States
Sponsor
University of California, San
View Trial →
NCT03866382 Phase 2
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) ...
Condition
Bladder Adenocarcinoma
Enrollment
314 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT04833465 N/A
Recruiting
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Condition
Juvenile Idiopathic Arthritis
Enrollment
90 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT05655325 N/A
Recruiting
Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Funct...
Condition
Mild Cognitive Impairment
Enrollment
144 pts
Location
United States
Sponsor
Columbia University
View Trial →
NCT07227168 Phase 1
Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Condition
Head and Neck Squamous Cell Carcinoma HNSCC
Enrollment
200 pts
Location
United States
Sponsor
Sutro Biopharma, Inc.
View Trial →
NCT05501704 Phase 2
Recruiting
ETHAN - ET for Male BC
Condition
Male Breast Cancer
Enrollment
60 pts
Location
United States
Sponsor
Jose Pablo Leone
View Trial →
Page 3 of 5 — 114 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology